| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President and CEO | President and CEO | Director
2 companies
Jacob Chacko is President and CEO at ORIC and has filed Form 4s across 2 companies. From April 2020 to December 2025, the filings on record show 2 open-market purchases and 22 sales. Jacob Chacko's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $5.6M at current prices.
Historically, Jacob Chacko's trades have earned a strong insider score of 77/100 across 41 rated trades. Over a 12-month horizon, 77.5% of those trades were profitable, with an average 12-month return of +45.0%.
The biggest single holding is ORIC (~$5.6M) as President and CEO. Net of sales, the ORIC filings show accumulation of 291,815 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 26, 2023 | ORIC Oric Pharmaceuticals, Inc. | President and CEO | Sell | 20,000 | $8.03 | $160,562.00 | -2.4% | -8.8% | -18.7% | |
| Apr 21, 2023 | FDMT 4d Molecular Therapeutics, Inc. | Director | Sale+OE10b5-1 | 5,000 | $20.05 | $100,269.50 | - | -17.3% | +15.9% | |
| Dec 15, 2022 | ORIC Oric Pharmaceuticals, Inc. | President and CEO | Sale+OE | 5,764 | $3.25 | $18,733.00 | -0.7% | +33.2% | +186.5% | |
| May 13, 2022 | ORIC Oric Pharmaceuticals, Inc. | President and CEO | Buy | 450,000 | $2.86 | $1,288,597.14 | +127.6% | +64.8% | +82.0% | |
| Mar 25, 2022 | ORIC Oric Pharmaceuticals, Inc. | President and CEO | Buy | 350,000 | $4.92 | $1,723,707.92 | +13,198% | -2.4% | +15.9% | |
| Sep 15, 2021 | ORIC Oric Pharmaceuticals, Inc. | President and CEO | Sell | 8,156 | $25.05 | $204,335.06 | -75.5% | -52.1% | -86.6% | |
| Sep 13, 2021 | ORIC Oric Pharmaceuticals, Inc. | President and CEO | Sell | 5,743 | $25.05 | $143,872.16 | -34.7% | -47.5% | -86.1% | |
| Sep 8, 2021 | ORIC Oric Pharmaceuticals, Inc. | President and CEO | Sell | 6,181 | $25.11 | $155,180.34 | -27.2% | -35.9% | -84.9% | |
| May 27, 2021 | ORIC Oric Pharmaceuticals, Inc. | President and CEO | Sell | 400 | $25.07 | $10,028.00 | -1.7% | -18.6% | -85.6% | |
| May 24, 2021 | ORIC Oric Pharmaceuticals, Inc. | President and CEO | Sell | 7,270 | $25.15 | $182,851.76 | -23.9% | -9.8% | -86.1% |